You are here: Industry Insights > targeted therapy

News List

A Glimpse of the Oncology Drug Treatment Market in China PharmaSources/Xiaoyaowan
May 31, 2021
According to statistics, the market size of China’s oncology treatment industry reached RMB387.6 billion in 2020, with a compound annual growth rate of 10.3% in the past five years as compared to RMB261.4 billion in 2016, and this market size is expected
MAIA Biotechnology Announces Additions to Executive Team and Board of Directors firstwordpharma
August 05, 2021
MAIA Biotechnology, Inc., today announced that it has appointed Mihail Obrocea, M.D., as Chief Medical Officer and Head of Development, and Charlotte Tsou as an independent member of its board of directors.
FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer fda.gov
May 24, 2021
Today, the U.S. Food and Drug Administration approved Rybrevant as the first treatment for adult patients with non-small cell lung cancer whose tumors have specific types of genetic mutations: EGFR exon 20 insertion mutations.
The First Bladder Cancer Targeted Therapy Filed the Import Drug Clinical Trial Applications to Start the Road of Marketing in China PharmaSources/Xiaoyaowan
December 04, 2019
According to the CDE website, the Erdafitinib Tablets developed by Janssen under J & J has recently been filed the import drug clinical trial applications in China ...
Potential first ever targeted therapy designed for ‘untreatable’ childhood brain cancer pharmatimes
May 12, 2019
Scientists at The Institute of Cancer Research, London have discovered a new type of drug that targets a genetic weakness in ‘diffuse intrinsic pontine glioma’ (DIPG), an untreatable childhood brain cancer, which could become the first ever treatment desi
FDA publishes two draft guidances on developing targeted therapies pharmaceutical-technology
December 20, 2017
FDA has published two new draft guidance documents that will provide clarity to medical product developers on the agency’s recommendations for researching and developing the next generation of individualised therapies.
Synthetic-biological hybrid nanocapsule combats diseased cells europeanpharmaceuticalreview
December 06, 2017
A new drug delivery system could provide a smart technology for the targeted treatment of a variety of serious diseases…